CXCL9 and infarction: Altara R observed increased expression of CXCL9 in both distant and near-infarct areas of the heart in rats, maintaining high levels for up to 16 weeks post-myocardial infarction, suggesting a continuous role of CXCL9 in post-infarction heart failure (23).